Endocrine disruptors in ESG analysis

Endocrine disruptors, the definition of which has not yet been ratified within the European Union, are chemicals that may affect the normal functioning of the endocrine glands to which humans may be exposed through different channels (WHO, 2012).

Their main characteristic is that their toxicity is not correlated with their dose (strong effects can be seen at low doses and slight effects at strong doses). This goes against the principle of Paracelsus, the father of toxicology, which asserts that the dose makes the poison.

Click to read the complete white paper on the site